NTRA
Natera, Inc.
Nasdaq Services-Medical Laboratories Large accelerated filer

Key Financials

Gross Profit
$38.8M
↑ 14.0%
Revenue
$2.3B
↑ 35.9%
Net Income
$-208160000
↓ 9.3%
Total Assets
$2.4B
↑ 44.4%
EPS (Diluted)
$-1.52
↑ 0.7%
Total Liabilities
$685.9M
↑ 47.4%
Operating Income
$-309911000
↓ 39.4%
Shareholders' Equity
$1.7B
↑ 43.2%

Recent SEC Filings

Form Type Filed Date Link
4 8/14/2026 View on SEC
SCHEDULE 13G/A 8/14/2026 View on SEC
4 8/7/2026 View on SEC
4 8/7/2026 View on SEC
144 8/7/2026 View on SEC
S-8 8/7/2026 View on SEC
144 8/7/2026 View on SEC
10-Q 8/7/2026 View on SEC
8-K 8/6/2026 View on SEC
4 8/5/2026 View on SEC

Company Information

Field Value
Ticker NTRA
Company Name Natera, Inc.
CIK 1604821
Sector Services-Medical Laboratories
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 8071
SIC Description Services-Medical Laboratories
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 650-249-9090